David Spigel
10 Podcast Episodes
Management of Unresectable Stage III Non-Small Cell Lung Cancer with Drs Jeffrey Bradley and David Spigel
Management of Unresectable Stage III Non-Small Cell Lung Cancer with Drs Jeffrey Bradley and David Spigel
Dr Jeffrey Bradley from the Emory University School of Medicine in Atlanta, Georgia, and Dr David Spigel from the Sarah ... Read more
1 Aug 2022
•
1hr 42mins
Meet Dr. David Spigel. Dedicated thoracic medical oncologist and Chief Scientific Officer at Sarah Cannon Research Institute. He's committed to bringing the latest innovative treatments to patients.
Meet Dr. David Spigel. Dedicated thoracic medical oncologist and Chief Scientific Officer at Sarah Cannon Research Institute. He's committed to bringing the latest innovative treatments to patients.
On today's episode, meet Dr. David Spigel. Dr. Spigel is the Chief Scientific Officer at Sarah Cannon Research Institute... Read more
26 Oct 2021
•
49mins
Similar People
Lecia Sequist
Charu Aggarwal
Nathan Pennell
Greg Riely
Ross Camidge
Stephen Liu
Heather Wakelee
Leora Horn
Anne Tsao
Pierre Onda
Rebecca Heist
Charles Rudin
Nasser Hanna
Anne-Marie Baird
Corey Langer
Medication For Lung Cancer Treatment With Dr. David Spigel
Medication For Lung Cancer Treatment With Dr. David Spigel
Dr. Jack West is joined by Dr. David Spigel to discuss medication for lung cancer treatment, checkpoint inhibitor therap... Read more
3 Jun 2019
•
20mins
Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer
Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of i... Read more
8 Mar 2019
•
20mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer (BMIC-075)
Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer (BMIC-075)
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of i... Read more
8 Mar 2019
•
20mins
Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer (BMIC-075)
Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer (BMIC-075)
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of i... Read more
8 Mar 2019
•
20mins
Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting (BMIC-074)
Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting (BMIC-074)
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical tr... Read more
5 Mar 2019
•
24mins
Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting
Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical tr... Read more
5 Mar 2019
•
24mins
Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting (BMIC-074)
Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting (BMIC-074)
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical tr... Read more
5 Mar 2019
•
24mins
Molecular Markers in Lung Cancer Pt 5: Dr. David Spigel on Incorporating Targets into Clinical Trials (audio)
Molecular Markers in Lung Cancer Pt 5: Dr. David Spigel on Incorporating Targets into Clinical Trials (audio)
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include pa... Read more
10 May 2012
•
24mins
